Status:
ACTIVE_NOT_RECRUITING
This Study Explores the Mental Health Impact of Two Akashic Records Sessions.
Lead Sponsor:
Rasa Healing Inc
Conditions:
Resilience
Connectedness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, a...
Detailed Description
The study aims to address the following research question: How do Akashic Records sessions impact mental health as evidenced by changes in self-reported stress, anxiety, and depression, and changes in...
Eligibility Criteria
Inclusion
- Inclusion:
- 18 years old and over
- Ability and willingness to provide written, informed consent in English prior to initiation of any study-related procedures and adhere to all study requirements
- Willingness to engage in discussion about past life patterns and emotions
- Self-report of anxiety, depressive or stress symptoms in the last 12 months
- Exclusion:
- Inability to provide consent due to cognitive impairment, mental health disorders, or other conditions that impact their ability to understand the nature, risks, and benefits of the study.
- History of alcohol or substance use disorder within 12 months
- History of hypomania or psychotic episode within 12 months
- Prior history (lifetime diagnosis) of schizophrenia spectrum, or other psychotic disorders
- Experiencing any other serious mental or physical health issues that would impact their ability to engage in the research study
- Has either attempted suicide, has documented medical history of suicidal ideation, or been hospitalized due to suicide risk within 1 year prior to prescreening.
- Previous Akashic Record Session with Interventionist, Candice S. Rasa, LCSW or previous Akashic Record Session with any other provider within 6 months.
- Any form of medicinal therapy should be stable 3 months prior to screening with no plan to start, stop or alter the use of any prescribed medications, supplements or other therapies from informed consent
- Any form of non-medical therapy should be stable 3 months prior to pre-screening with no plan to start, stop or alter use of psychotherapy, acupuncture, hypnosis, or other similar therapy from the time of providing informed consent.
Exclusion
Key Trial Info
Start Date :
June 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2026
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT07219914
Start Date
June 21 2024
End Date
January 22 2026
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virtual/ No Physical Facility
Palm City, Florida, United States, 34990